441 related articles for article (PubMed ID: 26769225)
1. Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.
Schmidt FM; Kirkby KC; Lichtblau N
Curr Neuropharmacol; 2016; 14(7):674-87. PubMed ID: 26769225
[TBL] [Abstract][Full Text] [Related]
2. Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.
Kohler O; Krogh J; Mors O; Benros ME
Curr Neuropharmacol; 2016; 14(7):732-42. PubMed ID: 27640518
[TBL] [Abstract][Full Text] [Related]
3. Immune System Modulators with Antidepressant Effects: Evidence from Animal Models.
Abelaira HM; Maciel AL; Quevedo J; Reus GZ
CNS Neurol Disord Drug Targets; 2017; 16(4):398-406. PubMed ID: 28393713
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.
Zhang JC; Yao W; Hashimoto K
Curr Neuropharmacol; 2016; 14(7):721-31. PubMed ID: 26786147
[TBL] [Abstract][Full Text] [Related]
5. Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease.
Zuzarte P; Duong A; Figueira ML; Costa-Vitali A; Scola G
Curr Drug Metab; 2018; 19(8):674-687. PubMed ID: 29512447
[TBL] [Abstract][Full Text] [Related]
6. Do Statins Have Antidepressant Effects?
Köhler-Forsberg O; Gasse C; Berk M; Østergaard SD
CNS Drugs; 2017 May; 31(5):335-343. PubMed ID: 28303466
[TBL] [Abstract][Full Text] [Related]
7. The Importance of the Structural Similarity of Drugs Used for Depression and Inflammation, Two Comorbid Diseases.
Bayram FEÖ; Reis R; Tunçer B; Sipahi H
Curr Top Med Chem; 2018; 18(16):1416-1421. PubMed ID: 30129414
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?
Catena-Dell'Osso M; Bellantuono C; Consoli G; Baroni S; Rotella F; Marazziti D
Curr Med Chem; 2011; 18(2):245-55. PubMed ID: 21110802
[TBL] [Abstract][Full Text] [Related]
9. New approaches to antidepressant drug design: cytokine-regulated pathways.
Nishida A; Miyaoka T; Inagaki T; Horiguchi J
Curr Pharm Des; 2009; 15(14):1683-7. PubMed ID: 19442181
[TBL] [Abstract][Full Text] [Related]
10. The immune system, depression and the action of antidepressants.
Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):767-80. PubMed ID: 11383977
[TBL] [Abstract][Full Text] [Related]
11. Is there evidence for an effect of antidepressant drugs on immune function?
Neveu PJ; Castanon N
Adv Exp Med Biol; 1999; 461():267-81. PubMed ID: 10442178
[No Abstract] [Full Text] [Related]
12. Antidepressant psychopharmacology: is inflammation a future target?
Benedetti F; Zanardi R; Mazza MG
Int Clin Psychopharmacol; 2022 May; 37(3):79-81. PubMed ID: 35357329
[TBL] [Abstract][Full Text] [Related]
13. Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.
Jha MK; Trivedi MH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29329256
[TBL] [Abstract][Full Text] [Related]
14. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.
Lopresti AL; Hood SD; Drummond PD
J Psychopharmacol; 2012 Dec; 26(12):1512-24. PubMed ID: 23035031
[TBL] [Abstract][Full Text] [Related]
15. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders.
Sun Y; Narayan VA; Wittenberg GM
BMC Pharmacol Toxicol; 2016 Oct; 17(1):47. PubMed ID: 27765060
[TBL] [Abstract][Full Text] [Related]
16. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response.
Janssen DG; Caniato RN; Verster JC; Baune BT
Hum Psychopharmacol; 2010 Apr; 25(3):201-15. PubMed ID: 20373471
[TBL] [Abstract][Full Text] [Related]
17. Drug disease interactions: role of inflammatory mediators in depression and variability in antidepressant drug response.
Kulmatycki KM; Jamali F
J Pharm Pharm Sci; 2006; 9(3):292-306. PubMed ID: 17207413
[TBL] [Abstract][Full Text] [Related]
18. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
Maes M
Neuro Endocrinol Lett; 2008 Jun; 29(3):287-91. PubMed ID: 18580840
[TBL] [Abstract][Full Text] [Related]
19. Novel approaches for the management of depressive disorders.
Kaster MP; Moretti M; Cunha MP; Rodrigues AL
Eur J Pharmacol; 2016 Jan; 771():236-40. PubMed ID: 26703867
[TBL] [Abstract][Full Text] [Related]
20. [Αnti-Inflammatory medication as adjunctive antidepressive treatment].
Boufidou F; Nikolaou C
Psychiatriki; 2016; 27(2):106-17. PubMed ID: 27467031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
